Trial intelligence / Profile preview

Nitrous Oxide Impact on PONV in Breast Surgeries

NCT02736604Completed

Sponsor
Tata Memorial Hospital
Start
May 2016
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of nitrous oxide in breast cancer (2 arms), sponsored by Tata Memorial Hospital. Primary endpoint: Incidence and severity of post operative nausea and vomiting at 24 hours. Started May 2016; status: completed.

02

Drugs

nitrous oxide
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02736604.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02736604.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call